India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes ...

Sun Pharmaceutical, India's largest drugmaker by revenue, plans to launch its experimental anti-obesity and type 2 diabetes ...

For Oscars 2025, there's a new trend in town: microdosing, taking tiny amounts of Ozempic and other weight-loss jabs is the ...

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. Let's figure out ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

Eli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people ...

Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.

Lilly plans to build four new pharmaceutical plants in the US, creating 13,000 jobs and bringing its recent domestic ...

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

Crowds are gathering in Vatican City and Rome to pray for the speedy recovery of Pope Francis. The 88-year-old pontiff has shown slight signs of improvement since he ...

Consumer Reports warns there are important considerations, especially for older adults, before starting these treatments.

Hugely popular weight loss drugs known as GLP-1's are finally getting cheaper, well at least one is, and that's the case with ...